ArticleInternational journal of hematology2026
Efficacy and safety of the BEBM (bendamustine, etoposide, busulfan, and melphalan) conditioning regimen for autologous stem-cell transplantation in non-Hodgkin lymphoma.
Sang Hun Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.